Preclinical Evaluation of the Efficacy of α-Difluoromethylornithine and Sulindac Against SARS-CoV-2 Infection.
Saved in:
| Title: | Preclinical Evaluation of the Efficacy of α-Difluoromethylornithine and Sulindac Against SARS-CoV-2 Infection. |
|---|---|
| Authors: | Ignatenko NA; Department of Cellular and Molecular Medicine, The University of Arizona, Tucson, AZ 85724, USA., Trinh HT; Valley Fever Center for Excellence, The University of Arizona, Tucson, AZ 85724, USA., Wagner AM; University Animal Care, The University of Arizona, Tucson, AZ 85724, USA., Gerner EW; Department of Cellular and Molecular Medicine, The University of Arizona, Tucson, AZ 85724, USA., Bime C; Department of Medicine, College of Medicine-Phoenix, The University of Arizona, Phoenix, AZ 85004, USA., Hsu CH; Mel and Enid Zuckerman College of Public Health, The University of Arizona, Tucson, AZ 85724, USA., Besselsen DG; University Animal Care, The University of Arizona, Tucson, AZ 85724, USA. |
| Source: | Viruses [Viruses] 2025 Sep 26; Vol. 17 (10). Date of Electronic Publication: 2025 Sep 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1999-4915 |
|---|---|
| DOI: | 10.3390/v17101306 |
